Clinically recognized steatotic liver disease

Disease

2 findings

“Clinically recognized SLD carried substantially higher all-cause mortality than uncoded SLD”
Artificial Intelligence-Assisted Opportunistic Computed Tomography for Steatotic Liver Disease Detection and Association with Cardiovascular and Mortality Outcomes in Adults with Cardiometabolic RiskAHA Scientific Sessions 2026 abstract2026doi:10.1161/circ.154.suppl_1.9297

Associations

2

3-point major adverse cardiovascular events

upin humans1RR 1.18

1 study
  1. Clinically recognized steatotic liver disease is associated with 3-point major adverse cardiovascular events in humans (Adjusted RR 1.18 (95% CI 0.87–1.59; p=0.29); 10.7% versus 8.9%).

    HumansClinically recognized versus clinically uncoded steatotic liver disease in adults with at least one cardiometabolic risk factor; adjusted for demographics and comorbiditiesMedian follow-up 2.2 years

Mortality

upin humans1RR 1.7

1 study
  1. Clinically recognized steatotic liver disease is associated with mortality in humans (Adjusted RR 1.70 (95% CI 1.31–2.21); 14.1% versus 9.6%).

    HumansClinically recognized versus clinically uncoded steatotic liver disease in adults with at least one cardiometabolic risk factor; adjusted for demographics and comorbiditiesMedian follow-up 2.2 years